艾迪注射液配合放射疗法治疗食管癌临床疗效观察

Clinical Observation Radiotherapy Combined with AiDi-Injection in the Treatment of Esophageal Carcinoma

目的:比较艾迪注射液加放疗与单纯放疗对食管癌的近期疗效及不良反应。方法:艾迪组43例放疗同期采用艾迪注射液60m l溶于5%葡萄糖注射液500m l中,静脉滴注,每天一次,疗程21天;对照组42例单纯放疗。结果:艾迪组近期有效率为79.1%,对照组为71.4%,统计学上差别无显著性(P>0.05),胃肠道及血液学不良反应,艾迪组均明显低于对照组(P<0.05)。结论:艾迪注射液配合放疗能有效降低食管癌放疗的不良反应。

Objective： To evaluate the short-term effect, side-effect of radiotherapy combined with AiDi-injection in the treatment of esophageal carcinoma. Methods： Fourty three cases of esophageal cancer as experiment group were treated with radiotherapy combined with AiDi-injection, 60ml dissolved in 5% glucose injection 500ml, qd, for 21days, intravenously. Meanwhile, 42 cases as control group were treated with radiotherapy. Results： The rate of short-term effect in experiment group was 79.1%, while the effective rate was 71.4% in the control group. There was not difference significant between the experiment group and control group （ P 〉 0. 05 ）. There was lower the incidence of gastrointestinal and hsomatological toxicity tendency in experiment group（ P 〈 0.05 ）. Conclusion： Radiotherapy combined with AiDi-injection is an efficacious and security treatment for esophageal cancer with low sideeffect.